EL.En. S.p.A. confirmed earnings guidance for the year 2023. So consolidated financial results for the first quarter of 2023 were perfectly in line with guidance for the full year of 2023.

The expectations on 2023 were stronger than at the end of 2022. The company still confident in ability to deliver another very strong performance in this year, but projections need to be more cautious in order to take into account a worldwide economic environment that is currently proofing to be older than expected. The company confirm the 2023 guidance has delivered last March.

Revenues will grow in 2023, both in the medical and in industrial sector. Due to several factors ranging from lower gross margins to increase sales and marketing expense into the general increase in expense from operation that the company reduce the operating leverage in the expected revenue range, the EBIT target for 2023 is to replicate the results of 2022.